Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 01 - 19 tags : Therapy save search
Atara Biotherapeutics to Present Data at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience
Published: 2021-01-19 (Crawled : 22:00) - biospace.com/
ATRA | $0.7101 -1.18% -1.2% 700K
|
Health Technology
|
| O: 4.27%
H: 1.98%
C: -1.98%
therapy
Clinical Data Presented at 2021 North American Neuromodulation Society (NANS) Virtual Meeting Reinforce Significant Benefits of Nevro's HF10® Therapy
Published: 2021-01-19 (Crawled : 18:00) - biospace.com/
NVRO | $12.51 -2.19% 0.0% 440K
|
Health Technology
|
| O: 1.84%
H: 0.69%
C: -0.41%
therapy
NeuroStar® Advanced Therapy’s Depression Outcomes Registry Hits 10,000 Patient MilestoneWorld’s largest Major Depressive Disorder registry results validate real-world outcomes; majority experience significant improvement
Published: 2021-01-19 (Crawled : 16:00) - biospace.com/
STIM | $3.76 -2.59% -2.66% 21K
|
Health Technology
|
| O: 6.76%
H: 13.73%
C: 13.0%
therapy results depression major depressive disorder
Francesco M. Marincola Joins Kite as Worldwide Head of Cell Therapy Research
Published: 2021-01-19 (Crawled : 15:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 2.21%
H: 5.29%
C: 3.62%
therapy research
XBiotech Announces Cerebrovascular Medical Advisory Board & Development of New Stroke TherapyAppointments Include: Chair, Clay Johnston, M.D., Ph.D. as well as Members Greg Albers, M.D. and Brett Cucchiara, M.D.
Published: 2021-01-19 (Crawled : 15:00) - biospace.com/
XBIT | $8.075 -1.28% -1.3% 65K
|
Health Technology
|
| O: 0.86%
H: 3.09%
C: 0.73%
therapy ev biotech stroke
Enveric Biosciences Issues Shareholder Letter Providing Strategic Vision for Advancing Novel Prescription Supportive Care Cancer Therapies
Published: 2021-01-19 (Crawled : 15:00) - biospace.com/
ENVB | $0.938 4.52% 4.33% 180K
|
Health Technology
|
| O: 2.78%
H: 0.74%
C: -0.74%
cancer therapy bioscience
Taysha Gene Therapies Receives Rare Pediatric Disease and Orphan Drug Designations for TSHA-105 for the Treatment of Epilepsy Caused by SLC13A5 Deficiency
Published: 2021-01-19 (Crawled : 15:00) - biospace.com/
TSHA | $2.355 -6.92% -7.43% 790K
|
Health Technology
|
| O: 1.83%
H: 10.72%
C: 2.92%
disease drug gene therapies therapy treatment gene therapy designation rare
Neovasc Reducer Featured in Three Peer Reviewed Publications Supporting Reducer Therapy
Published: 2021-01-19 (Crawled : 14:01) - globenewswire.com
NVCN | $30.03 1.66% -2.02% 0
|
Health Technology
|
| O: -18.4%
H: 19.49%
C: 12.34%
therapy
Veru Announces Nature Medicine Publication Demonstrating that Enobosarm, an Androgen Receptor Targeted Agent, Inhibits Hormone Receptor Positive Metastatic Breast Cancer that has Become Resistant to Estrogen Receptor Targeted Endocrine and CDK4/6 Inhibitor Therapies
Published: 2021-01-19 (Crawled : 14:01) - globenewswire.com
VERU | $1.325 3.92% 3.77% 1.5M
|
Health Technology
|
| O: 4.43%
H: 1.19%
C: -4.4%
positive endocrine cancer breast cancer hormone therapy metastatic breast cancer
XBiotech Announces Cerebrovascular Medical Advisory Board & Development of New Stroke Therapy
Published: 2021-01-19 (Crawled : 14:00) - globenewswire.com
XBIT | $8.075 -1.28% -1.3% 65K
|
Health Technology
|
| O: 0.86%
H: 3.09%
C: 0.73%
therapy biotech stroke
Seven-year Data Shows Accuray TomoTherapy® System Provides Excellent Long-Term Control of Low-Risk Breast Cancer
Published: 2021-01-19 (Crawled : 13:07) - prnewswire.com
ARAY | $2.2 -0.9% -0.91% 290K
|
Health Technology
|
| O: 4.42%
H: 0.3%
C: -4.03%
therapy cancer risk breast cancer insiders selling
NeuroStar® Advanced Therapy’s Depression Outcomes Registry Hits 10,000 Patient Milestone
Published: 2021-01-19 (Crawled : 13:03) - globenewswire.com
STIM | $3.76 -2.59% -2.66% 21K
|
Health Technology
|
| O: 6.76%
H: 13.73%
C: 13.0%
therapy depression milestone
Advaxis Announces Receipt of Funding Milestone Payment Under ADXS-HER2 Licensing Agreement with OS Therapies
Published: 2021-01-19 (Crawled : 13:03) - globenewswire.com
ADXS | $0.54 12.48% 950
|
Health Technology
|
| O: 4.9%
H: 18.77%
C: 12.14%
therapy license her2+ milestone her2- her2
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.